Photocure
Presença
Photocure é uma empresa listada sob o símbolo PHO (NO).
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da Photocure
- Daniel Schneider, President and Chief Executive Officer
- Johanna Holldack, Director
- Neal Shore, Director
Recentes movimentos de executivos em Photocure
- Jan Egberts, Chairman of the Board, deixou a Companhia (Notícia publicada em 28 de setembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Photocure.
Farmacêutica
Photocure possui 1.867 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Photocure
- EAU 2024: Photocure Partner Asieris to present the Drug and Equipment Performance Results from the Chinese Phase III Clinical Study of Hexvix in Combination with HD 4K Blue Light Cystoscopy equipment
- Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
- New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
- Canadian Health Authorities approve updated and expanded label for Cysview
- Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
- Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results
- Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO
- Photocure ASA: Results for the fourth quarter of 2023
- Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
- View more press releases Close
Redes sociais sobre Photocure
- Photocure na Wikipedia, Google News e Yahoo Finance
- Photocure na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Daniel Schneider 
Ligue para a Photocure em +47 ...
